. Author manuscript; available in PMC: 2011 Oct 1.

Published in final edited form as: Cancer Res. 2010 Sep 28;70(19):7411–7420. doi: 10.1158/0008-5472.CAN-10-1438

Table 2.

Frequency of amplifications and deletions in murine BCR-ABL1 leukemias

Cohort	N	*Amplifications^ (mean ± s.d.)^	*Deletions^ (mean ± s.d.)^	*All Lesions^ (mean ± s.d.)^
AID^-/-	3	17.0 ± 2.0 (15-19)	10.7 ± 2.1 (9-13)	27.7 ± 0.6 (27-28)
AID^+/+	3	45.3 ± 6.7 (38-51)	40.0 ± 7.2 (34-48)	85.3 ± 11.9 (72-95)

There are significant differences of amplifications (p=0.0021), deletions (p=0.0025) and all lesions (p=0.0011) between AID^-/- leukemia and AID^+/+ leukemia as determined by Student's t test.

^**

Range shown in parentheses. Mean values were calculated based on the analysis of three tumor samples from three different mice per cohort.